These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32590803)

  • 1. Apoptosis in cerebrospinal fluid as outcome predictors in severe traumatic brain injury: An observational study.
    Jiang W; Jin P; Wei W; Jiang W
    Medicine (Baltimore); 2020 Jun; 99(26):e20922. PubMed ID: 32590803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detectable levels of cytochrome C and activated caspase-9 in cerebrospinal fluid after human traumatic brain injury.
    Darwish RS; Amiridze NS
    Neurocrit Care; 2010 Jun; 12(3):337-41. PubMed ID: 20087688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential changes in Rotterdam CT scores related to outcomes for patients with traumatic brain injury who undergo decompressive craniectomy.
    Fujimoto K; Miura M; Otsuka T; Kuratsu J
    J Neurosurg; 2016 Jun; 124(6):1640-5. PubMed ID: 26495949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome.
    Pérez-Bárcena J; Crespí C; Frontera G; Llompart-Pou JA; Salazar O; Goliney V; Ibáñez J; Bullock MR; de Rivero Vaccari JP
    J Neurosurg; 2020 May; 134(5):1644-1649. PubMed ID: 32357337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
    Pineda JA; Lewis SB; Valadka AB; Papa L; Hannay HJ; Heaton SC; Demery JA; Liu MC; Aikman JM; Akle V; Brophy GM; Tepas JJ; Wang KK; Robertson CS; Hayes RL
    J Neurotrauma; 2007 Feb; 24(2):354-66. PubMed ID: 17375999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylurea Receptor-1: A Novel Biomarker for Cerebral Edema in Severe Traumatic Brain Injury.
    Jha RM; Puccio AM; Chou SH; Chang CH; Wallisch JS; Molyneaux BJ; Zusman BE; Shutter LA; Poloyac SM; Janesko-Feldman KL; Okonkwo DO; Kochanek PM
    Crit Care Med; 2017 Mar; 45(3):e255-e264. PubMed ID: 27845954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome.
    Zemlan FP; Jauch EC; Mulchahey JJ; Gabbita SP; Rosenberg WS; Speciale SG; Zuccarello M
    Brain Res; 2002 Aug; 947(1):131-9. PubMed ID: 12144861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury.
    Au AK; Aneja RK; Bell MJ; Bayir H; Feldman K; Adelson PD; Fink EL; Kochanek PM; Clark RS
    J Neurotrauma; 2012 Jul; 29(11):2013-21. PubMed ID: 22540160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of apoptosis in cerebrospinal fluid of patients with severe head injury.
    Uzan M; Erman H; Tanriverdi T; Sanus GZ; Kafadar A; Uzun H
    Acta Neurochir (Wien); 2006 Nov; 148(11):1157-64; discussion. PubMed ID: 16964558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
    Lindblad C; Pin E; Just D; Al Nimer F; Nilsson P; Bellander BM; Svensson M; Piehl F; Thelin EP
    Crit Care; 2021 Mar; 25(1):103. PubMed ID: 33712077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury.
    Brophy GM; Pineda JA; Papa L; Lewis SB; Valadka AB; Hannay HJ; Heaton SC; Demery JA; Liu MC; Tepas JJ; Gabrielli A; Robicsek S; Wang KK; Robertson CS; Hayes RL
    J Neurotrauma; 2009 Apr; 26(4):471-9. PubMed ID: 19206997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury.
    Anderson TN; Hwang J; Munar M; Papa L; Hinson HE; Vaughan A; Rowell SE
    J Trauma Acute Care Surg; 2020 Jul; 89(1):80-86. PubMed ID: 32251265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of changes in brain tissue oxygen pressure before and after decompressive craniectomy following severe traumatic brain injury.
    Lubillo ST; Parrilla DM; Blanco J; Morera J; Dominguez J; Belmonte F; López P; Molina I; Ruiz C; Clemente FJ; Godoy DA
    J Neurosurg; 2018 May; 128(5):1538-1546. PubMed ID: 28665250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome c, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse.
    Satchell MA; Lai Y; Kochanek PM; Wisniewski SR; Fink EL; Siedberg NA; Berger RP; DeKosky ST; Adelson PD; Clark RS
    J Cereb Blood Flow Metab; 2005 Jul; 25(7):919-27. PubMed ID: 15744250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury.
    Papa L; Akinyi L; Liu MC; Pineda JA; Tepas JJ; Oli MW; Zheng W; Robinson G; Robicsek SA; Gabrielli A; Heaton SC; Hannay HJ; Demery JA; Brophy GM; Layon J; Robertson CS; Hayes RL; Wang KK
    Crit Care Med; 2010 Jan; 38(1):138-44. PubMed ID: 19726976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
    Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
    Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Translocator Protein in Brain Tissue Following Traumatic Brain Injury.
    Bao Q; Yuan X; Bian X; Wei W; Jin P; Jiang W
    Turk Neurosurg; 2023; 33(5):736-744. PubMed ID: 35416274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.